HMG-COA REDUCTASE INHIBITORS(STATINS) IN THE TREATMENT OF ALZHEIMER'S DISEASE AND WHY IT WOULD BE ILL-ADVISED TO USE ONE THAT CROSSES THE BLOOD-BRAIN BARRIER

SPARKS, D.L., CONNOR, D.J., BROWNE, P.J., LOPEZ, J.E., & SABBAGH, M.N.. (2002). HMG-COA REDUCTASE INHIBITORS(STATINS) IN THE TREATMENT OF ALZHEIMER'S DISEASE AND WHY IT WOULD BE ILL-ADVISED TO USE ONE THAT CROSSES THE BLOOD-BRAIN BARRIER. JOURNAL OF NUTRITION, HEALTH AND AGING, 6(-), 324-331. SID. https://sid.ir/paper/557150/en

SPARKS D.L., CONNOR D.J., BROWNE P.J., LOPEZ J.E., SABBAGH M.N.. HMG-COA REDUCTASE INHIBITORS(STATINS) IN THE TREATMENT OF ALZHEIMER'S DISEASE AND WHY IT WOULD BE ILL-ADVISED TO USE ONE THAT CROSSES THE BLOOD-BRAIN BARRIER. JOURNAL OF NUTRITION, HEALTH AND AGING[Internet]. 2002;6(-):324-331. Available from: https://sid.ir/paper/557150/en

D.L. SPARKS, D.J. CONNOR, P.J. BROWNE, J.E. LOPEZ, and M.N. SABBAGH, “HMG-COA REDUCTASE INHIBITORS(STATINS) IN THE TREATMENT OF ALZHEIMER'S DISEASE AND WHY IT WOULD BE ILL-ADVISED TO USE ONE THAT CROSSES THE BLOOD-BRAIN BARRIER,” JOURNAL OF NUTRITION, HEALTH AND AGING, vol. 6, no. -, pp. 324–331, 2002, [Online]. Available: https://sid.ir/paper/557150/en